University Medical Center Groningen

This Phase 3 trial tests whether dapagliflozin (Forxiga), a drug originally for diabetes, can reduce the risk of death, kidney failure, and heart failure hospitalization in 1750 people with severe chronic kidney disease. Unlike earlier studies, this trial includes patients on dia…

This phase 3 trial compares two treatment approaches for high-risk rectal cancer. The experimental group gets a short course of radiation (5 days) followed by several months of chemotherapy before surgery. The standard group receives longer chemoradiotherapy followed by surgery a…

This study tests whether giving the immunotherapy drug pembrolizumab before standard surgery can shrink tumors in people with a specific type of uterine cancer (MMRd). Twelve participants will receive 9 cycles of pembrolizumab before their hysterectomy. The goal is to see how man…

This study tests whether the drug finerenone can lower protein levels in the urine of people with chronic kidney disease who are not taking certain blood pressure medications. About 180 adults will receive either finerenone or a placebo for 6 months. The goal is to see if fineren…

This study uses PET scans to look at the brain's reward system in 30 people who had bariatric surgery 2-3 years ago. Researchers want to see if differences in dopamine receptors explain why some patients lose more weight than others. Participants will have brain scans before and …

This study uses stem cells made from patients' own cells to understand why some people develop severe heart or lung side effects from certain chemotherapy drugs. Researchers will compare cells from patients who had extreme toxicity to those who did not. The goal is to uncover the…

This pilot study tests a new PET imaging method using a tracer called 89Zr-atezolizumab to see if it can predict how well patients with large B-cell lymphoma respond to CAR T-cell therapy. The study involves 20 participants and aims to determine if this imaging can also tell the …

This study looks at how cancer immunotherapy changes the immune cells in the gut. Researchers will take small tissue samples from the colon and blood samples before and during treatment in 38 patients. The goal is to better understand gut-related side effects, not to test a new d…

This study follows nearly 1,000 testicular cancer survivors to understand why they have a higher risk of heart disease. Researchers are looking at how cancer treatments like chemotherapy may damage blood vessels or lead to risk factors like high blood pressure. The goal is to imp…